One of the most critical phases in drug development are the preclinical studies to determine the safety and toxicity profile of the drug compound. We follow FDA guidelines and good laboratory practices (GLP) in performing in vitro and in vivo preclinical research. At HistoTox Labs and HTL Clinical, we meet or exceed GLP requirements for:
- Proper study conduct
- Certified and trained personnel
- Adequate facilities
- State-of-the-art equipment
- Precise and complete written protocals and study reports
- Current standard operating procedures
- Quality assurance system
Through our parent company, HistoTox Labs, we offer over 17 years of preclinical research experience, a board range of services, and experienced teams to guide and complete cost-effective preclinical studies within budgetary constraints.
To learn more about our preclinical services, please fill out the contact section below.
Reach out to get the latest in pricing and services.